(R)-10-(3-Hydroxy-3-(5-methylisoxazol-3-yl)but-1-yn-1-yl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide

Catalog No. :
ACDDRX840
CAS No. :
1451079-18-7
Molecular Formula :
C22H21N5O5
Molecular Weight :
435.44

IUPAC Name:(R)-10-(3-Hydroxy-3-(5-methylisoxazol-3-yl)but-1-yn-1-yl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide

(R)-10-(3-Hydroxy-3-(5-methylisoxazol-3-yl)but-1-yn-1-yl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-10-(3-Hydroxy-3-(5-methylisoxazol-3-yl)but-1-yn-1-yl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide
IUPAC Name(R)-10-(3-Hydroxy-3-(5-methylisoxazol-3-yl)but-1-yn-1-yl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide
Molecular FormulaC22H21N5O5
Molecular Weight435.44
SMILESCNC(=O)C1=C(C(N)=O)N=C2C3=CC(C#C[C@@](C)(O)C4=NOC(C)=C4)=CC=C3OCCN21
InChI KeyHYLUNVLDXOSFLG-JOCHJYFZSA-N
SynonymImidazo[1,2-d][1,4]benzoxazepine-2,3-dicarboxamide, 5,6-dihydro-10-[(3R)-3-hydroxy-3-(5-methyl-3-isoxazolyl)-1-butyn-1-yl]-N3-methyl-
CAS No.1451079-18-7

Synthetic Route by SureRoute

1. ACDDRX840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDRX840 route product structure diagram
    ACDDRX8401451079-18-7
Inquiry

2. ACDDRX840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDRX840 route product structure diagram
    ACDDRX8401451079-18-7
Inquiry

Comments (0)